Nisa Investment Advisors LLC Sells 854 Shares of IBM (NYSE:IBM)

Nisa Investment Advisors LLC trimmed its position in shares of IBM (NYSE:IBM) by 0.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 315,307 shares of the technology company’s stock after selling 854 shares during the quarter. Nisa Investment Advisors LLC’s holdings in IBM were worth $44,490,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of IBM. Swedbank grew its position in IBM by 3.2% during the fourth quarter. Swedbank now owns 1,159,250 shares of the technology company’s stock valued at $131,030,000 after acquiring an additional 35,526 shares during the period. Glenmede Trust Co. NA grew its position in IBM by 9.1% during the third quarter. Glenmede Trust Co. NA now owns 456,696 shares of the technology company’s stock valued at $69,056,000 after acquiring an additional 38,181 shares during the period. MUFG Securities EMEA plc grew its position in IBM by 44.8% during the fourth quarter. MUFG Securities EMEA plc now owns 216,780 shares of the technology company’s stock valued at $24,641,000 after acquiring an additional 67,055 shares during the period. Oak Associates Ltd. OH grew its position in IBM by 1.3% during the fourth quarter. Oak Associates Ltd. OH now owns 184,274 shares of the technology company’s stock valued at $20,946,000 after acquiring an additional 2,403 shares during the period. Finally, Accident Compensation Corp grew its position in IBM by 2.9% during the fourth quarter. Accident Compensation Corp now owns 52,981 shares of the technology company’s stock valued at $6,022,000 after acquiring an additional 1,500 shares during the period. Institutional investors own 55.65% of the company’s stock.

Shares of IBM opened at $135.34 on Friday. The stock has a market capitalization of $123.68 billion, a P/E ratio of 9.80, a price-to-earnings-growth ratio of 2.55 and a beta of 1.23. IBM has a one year low of $105.94 and a one year high of $154.36. The company has a quick ratio of 1.31, a current ratio of 1.36 and a debt-to-equity ratio of 2.39.

IBM (NYSE:IBM) last issued its quarterly earnings results on Tuesday, April 16th. The technology company reported $2.25 EPS for the quarter, beating analysts’ consensus estimates of $2.22 by $0.03. The firm had revenue of $18.18 billion during the quarter, compared to the consensus estimate of $18.53 billion. IBM had a return on equity of 68.76% and a net margin of 10.98%. IBM’s revenue for the quarter was down 4.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.45 earnings per share. On average, research analysts anticipate that IBM will post 13.89 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 10th. Shareholders of record on Friday, May 10th will be paid a dividend of $1.62 per share. The ex-dividend date of this dividend is Thursday, May 9th. This represents a $6.48 annualized dividend and a yield of 4.79%. This is a boost from IBM’s previous quarterly dividend of $1.57. IBM’s dividend payout ratio is presently 45.47%.

A number of equities research analysts have issued reports on IBM shares. Cantor Fitzgerald reissued a “hold” rating and set a $140.00 price target on shares of IBM in a research report on Wednesday, January 16th. Citigroup boosted their price target on IBM from $130.00 to $140.00 and gave the company a “neutral” rating in a research report on Wednesday, April 17th. ValuEngine raised IBM from a “sell” rating to a “hold” rating in a research report on Wednesday, February 13th. BMO Capital Markets upped their target price on IBM from $147.00 to $155.00 and gave the stock a “market perform” rating in a research report on Wednesday, April 17th. They noted that the move was a valuation call. Finally, Zacks Investment Research raised IBM from a “sell” rating to a “hold” rating in a research report on Monday, April 22nd. Two investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and seven have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $155.72.

In other IBM news, insider Erich Clementi sold 13,000 shares of the company’s stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $139.01, for a total transaction of $1,807,130.00. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Diane J. Gherson sold 1,989 shares of the stock in a transaction that occurred on Wednesday, February 13th. The stock was sold at an average price of $137.25, for a total value of $272,990.25. The disclosure for this sale can be found here. Insiders have sold 15,113 shares of company stock worth $2,096,923 in the last 90 days. 0.19% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by Baseball Daily News and is owned by of Baseball Daily News. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The original version of this piece of content can be viewed at https://www.baseballdailydigest.com/news/2019/05/10/ibm-ibm-shares-sold-by-nisa-investment-advisors-llc.html.

About IBM

International Business Machines Corporation operates as an integrated technology and services company worldwide. Its Cognitive Solutions segment offers a portfolio of enterprise artificial intelligence platforms, such as analytics and data management platforms, cloud data services, talent management, and industry solutions primarily under the Watson Platform, Watson Health, and Watson Internet of Things names.

Featured Story: Debt-To-Equity Ratio

Institutional Ownership by Quarter for IBM (NYSE:IBM)

Receive News & Ratings for IBM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBM and related companies with MarketBeat.com's FREE daily email newsletter.